These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10810513)

  • 41. mt1 Melatonin receptor in the primate adrenal gland: inhibition of adrenocorticotropin-stimulated cortisol production by melatonin.
    Torres-Farfan C; Richter HG; Rojas-García P; Vergara M; Forcelledo ML; Valladares LE; Torrealba F; Valenzuela GJ; Serón-Ferré M
    J Clin Endocrinol Metab; 2003 Jan; 88(1):450-8. PubMed ID: 12519889
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Investigation into the contractile response of melatonin in the guinea-pig isolated proximal colon: the role of 5-HT4 and melatonin receptors.
    Lucchelli A; Santagostino-Barbone MG; Tonini M
    Br J Pharmacol; 1997 Aug; 121(8):1775-81. PubMed ID: 9283717
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Structure and function of melatonin receptors].
    Jockers R; Petit L; Brydon L; de Coppet P; Strosberg AD
    C R Seances Soc Biol Fil; 1998; 192(4):659-67. PubMed ID: 9842470
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Melatonin receptors mediate contraction of a rat cerebral artery.
    Viswanathan M; Scalbert E; Delagrange P; Guardiola-Lemaître B; Saavedra JM
    Neuroreport; 1997 Dec; 8(18):3847-9. PubMed ID: 9462453
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Can melatonin regulate the expression of prohormone convertase 1 and 2 genes via monomeric and dimeric forms of RZR/ROR nuclear receptor, and can melatonin influence the processes of embryogenesis or carcinogenesis by disturbing the proportion of cAMP and cGMP concentrations? Theoretic model of controlled apoptosis.
    Cieśla W
    Med Hypotheses; 2001 Feb; 56(2):181-93. PubMed ID: 11425285
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Melatonin and biological rhythms].
    Pevet P
    Therapie; 1998; 53(5):411-20. PubMed ID: 9921032
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Melatonin: receptor-mediated events that may affect breast and other steroid hormone-dependent cancers.
    Baldwin WS; Barrett JC
    Mol Carcinog; 1998 Mar; 21(3):149-55. PubMed ID: 9537645
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gastrointestinal melatonin: localization, function, and clinical relevance.
    Bubenik GA
    Dig Dis Sci; 2002 Oct; 47(10):2336-48. PubMed ID: 12395907
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Investigation of the human Mel 1a melatonin receptor using anti-receptor antibodies.
    Brydon L; Barrett P; Morgan PJ; Strosberg AD; Jockers R
    Adv Exp Med Biol; 1999; 460():215-20. PubMed ID: 10810516
    [No Abstract]   [Full Text] [Related]  

  • 50. Genetic and physical mapping of the porcine melatonin receptor 1B gene (MTNR1B) to chromosome 9.
    Skinner TM; Lopez-Corrales NL; Anderson SI; Loudon AL; Haley CS; Archibald AL
    Cytogenet Cell Genet; 2000; 90(1-2):53-5. PubMed ID: 11060444
    [No Abstract]   [Full Text] [Related]  

  • 51. Melatonin madness.
    Reppert SM; Weaver DR
    Cell; 1995 Dec; 83(7):1059-62. PubMed ID: 8548792
    [No Abstract]   [Full Text] [Related]  

  • 52. Melatonin binding sites in the central nervous system.
    Stankov B; Fraschini F; Reiter RJ
    Brain Res Brain Res Rev; 1991; 16(3):245-56. PubMed ID: 1665096
    [No Abstract]   [Full Text] [Related]  

  • 53. Mapping of the melatonin receptor 1a (MTNR1A) gene in pigs, sheep, and cattle.
    Messer LA; Wang L; Tuggle CK; Yerle M; Chardon P; Pomp D; Womack JE; Barendse W; Crawford AM; Notter DR; Rothschild MF
    Mamm Genome; 1997 May; 8(5):368-70. PubMed ID: 9107687
    [No Abstract]   [Full Text] [Related]  

  • 54. The antiproliferative effects of melatonin on experimental pituitary and colonic tumors. Possible involvement of the putative nuclear binding site?
    Pawlikowski M; Kunert-Radek J; Winczyk K; Melen-Mucha G; Gruszka A; Karasek M
    Adv Exp Med Biol; 1999; 460():369-72. PubMed ID: 10810534
    [No Abstract]   [Full Text] [Related]  

  • 55. Melatonin receptors: are there multiple subtypes?
    Dubocovich ML
    Trends Pharmacol Sci; 1995 Feb; 16(2):50-6. PubMed ID: 7762083
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vascular melatonin receptors.
    Viswanathan M; Laitinen JT; Saavedra JM
    Biol Signals; 1993; 2(4):221-7. PubMed ID: 8205165
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Specific binding of melatonin by immunocompetent cells in humans and rodents. Modifications during postnatal development.
    Guerrero JM; Lopez-Gonzalez MA; Osuna C; Calvo JR
    Ann N Y Acad Sci; 1994 May; 719():369-77. PubMed ID: 8010607
    [No Abstract]   [Full Text] [Related]  

  • 58. Discussion of the comparative physiology of serotonin and melatonin.
    Bloom FE
    Adv Pharmacol (1962); 1968; 6(Pt A):298-300. PubMed ID: 5664052
    [No Abstract]   [Full Text] [Related]  

  • 59. Endocrine disruptors signal the need for receptor models and mechanisms to inform policy.
    Limbird LE; Taylor P
    Cell; 1998 Apr; 93(2):157-63. PubMed ID: 9568709
    [No Abstract]   [Full Text] [Related]  

  • 60. CNS-targeted sexual dysfunction drug for men and women.
    Clough J
    Drug Discov Today; 2002 May; 7(9):492-3. PubMed ID: 11983559
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.